When was Almac Group founded?

Almac Group was founded in 2001 and raised its 1st funding round 6 years after it was founded.

Where is Almac Group located?

Almac Group is headquartered in Craigavon, United Kingdom. It is registered at Souderton,Pennsylvania.

Who is the current CEO of Almac Group?

Alan Armstrong of Almac Group. They have also founded 1 company.

How many employees does Almac Group have?

As of Apr 30, 2026, the latest employee count at Almac Group is 4863.

Is Almac Group a funded company?

Almac Group is a funded company, having raised a total of $339M across 15 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 01, 2007.

How much is Almac Group worth?

The latest valuation of Almac Group is $***** as of May 31, 2019.

When was the latest funding round of Almac Group?

Almac Group's latest funding was a $***** Grant (prize money) round on Sep 06, 2022, with participation from 1 investor.

Where does Almac Group rank among its competitors?

Almac Group ranks 2nd amongst 369 active competitors, of which 16 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Nucleus RadioPharma, which secured an undisclosed amount in Jun, 2024.

Who are the top competitors of Almac Group?

Almac Group's top competitors include Aizant, Concord Biotech and Nucleus RadioPharma. Among them, Nucleus RadioPharma secured the most recent funding round in June, 2024.

Almac Group - 2026 Company Profile, Team, Funding, Competitors & Financials

Almac Group is a series D company based in Craigavon (United Kingdom), founded in 2001 by Alan Armstrong. It operates as a CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development. Almac Group has raised $339M in funding from Genomic Health, with a current valuation of $*****. The company has 369 active competitors, including 16 funded and 91 that have exited. Its top competitors include companies like Aizant, Concord Biotech and Nucleus RadioPharma.

Company Details

Almac is a contract development and manufacturing organisation that provides a range of integrated services to biopharma companies. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, companion diagnostics development, analytical services, commercial manufacturing services and clinical technologies. The company has facilities in Europe, North America and Asia.

Website: www.almacgroup.com/
Social
Registered Address: Souderton,Pennsylvania

Key Metrics

Founded Year

2001

Location

Craigavon, United Kingdom

Stage

Series D

Total Funding

$339M in 15 rounds

Latest Funding Round

Grant (prize money), Sep 06, 2022, $*****

Post Money Valuation

$***** as on May 31, 2019

Investors

Genomic Health & 5 more

Ranked

2^nd among 369 active competitors

Employee Count

4,863 as on Apr 30, 2026

Investment & Acquisitions

BioClin Labs & 2 more

Similar Companies

Aizant & 414 more

View Almac Group's full profile

Almac Group is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ALMAC ApS CIN: 31765013 , Denmark, Active	Aug 31, 2008	$10.7K (As on Dec 31, 2013)	-
ALMAC GROUP LIMITED CIN: NI041551 , United Kingdom, Active	Sep 19, 2001	$1.18B (As on Sep 30, 2023)	5783 (As on Sep 30, 2021)
ALMAC GROUP, INC. CIN: 261549369 , United States, Active	Dec 31, 1999	-	2128 (As on Dec 31, 2024)	-

Almac Group has raised a total funding of $339M over 15 rounds. Its first funding round was on May 01, 2007. Its latest funding round was a Grant (prize money) round on Sep 06, 2022 for $*****. 1 investor participated in its latest round. Almac Group has 6 institutional investors.

Here is the list of recent funding rounds of Almac Group:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 06, 2022	9074692	Grant (prize money)	6624004	6417343	5681217	3027238
Jan 12, 2021	1917354	Grant (prize money)	3994947	1763806	8104998	Invest Northern Ireland & 1 more
May 28, 2020	1845981	Grant (prize money)	6469754	3156672	8457361	Gates

Access funding benchmarks and valuations. Sign up today!

View details of Almac Group's funding rounds and investors

The founders of Almac Group is Alan Armstrong. Alan Armstrong is the CEO of Almac Group.

Here are the details of Almac Group's key team members:

Alan Armstrong: CEO & Chairman of Almac Group. They serve on the board of 1 company.

Almac Group's Board of Directors

Almac Group's board has 2 active members. Alan Armstrong and Colin Hayburn are part of team.

Here is the list of Almac Group's board of directors:

Name	Type	Representing	Status	Duration
Alan Armstrong	Team	-	Current	24y 6m
{ppftwn	Team	-	Current	1y 5m
pmqvkvd	Team	-	Past	8y 9m
tlmexvd	Team	-	Past	8y 6m
{tlzmih	Independent board member	-	Past	1y 6m
zobuddj	Independent board member	-	Past	8y 8m
yvo{tqc	Independent board member	-	Past	2y 5m
zoxbsjy	Independent board member	-	Past	3y 7m

View details of Almac Group's Founder profiles and Board Members

Almac Group's employee count trend

Almac Group has 4,863 employees as of Apr 26. Here is Almac Group's employee count trend over the years:

Uncover Almac Group's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Almac Group include Aizant, Concord Biotech and Nucleus RadioPharma. Here is the list of Top 10 competitors of Almac Group, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aizant 2005, Hyderabad (India), Series A	Company offering contract development services for small molecules	$16.8M	Zephyr Management, Zephyr Peacock & 39 others	59/100
2nd	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Invest Northern Ireland, Gates & 4 others	57/100
3rd	Concord Biotech 2000, Ahmedabad (India), Public	CDMO focused on manufacturing API	-	Quadria Capital, Helix Investments & 18 others	56/100
4th	Nucleus RadioPharma 2022, Rochester (United States), Series A	CDMO focused on providing of radiopharmaceuticals manufacturing and supply chain services	$72.1M	Eclipse, Astrazeneca & 7 others	55/100
5th	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	54/100
6th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	53/100
7th	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	52/100
8th	Sabinsa 1988, East Windsor (United States), Unfunded	Manufacturing and marketing nutraceuticals, cosmeceuticals and fine chemicals	-	-	52/100
9th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	52/100
10th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	51/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Almac Group's competitors? Click here to see the top ones

Almac Group has acquired 3 companies including BioClin Labs, Arran Chemical and BioClin Labs. Almac Group has not made any investments as of now.

Here is the list of its acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Nov 01, 2017	Acquisition	BioClin Labs	2003	Athlone (Ireland)
Nov 03, 2015	Acquisition	Arran Chemical	1984	Athlone (Ireland)
Feb 12, 2008	Acquisition	BioClin Labs	2003	Athlone (Ireland)